好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

A Machine Learning Algorithm for Predicting Outcome after Subarachnoid Hemorrhage
Neuro Trauma, Critical Care, and Sports Neurology
S26 - Neurocritical Care (2:32 PM-2:40 PM)
004

Develop an automated algorithm using quantitative EEG (qEEG) to predict discharge Glasgow outcome scale (GOS) after subarachnoid hemorrhage (SAH).

Continuous electroencephalography (EEG) is used for monitoring after SAH. Seizures, epileptiform abnormality burden, and quantitative EEG measures such as alpha power predict outcome after SAH (De Marchis 2015, Zafar 2018, Gollwitzer 2019). We hypothesized that machine learning combining multiple qEEG features improves outcome prediction after SAH.

We retrospectively analyzed patients with moderate to severe SAH (HH3-5 or FS3-4; 2011-2015) who were monitored with continuous EEG. We dichotomized GOS at discharge as poor (GOS=1-3) or good (GOS=4-5). We extracted eight qEEG features: total power, delta power, theta power, alpha power, alpha delta ratio (ADR), percent alpha variability (PAV), Shannon entropy and epileptiform discharge (ED) burden (defined as the number of sporadic or periodic discharges detected per hour). We used Persyst to identify EDs and used Matlab to calculate all features. We trained random forest models to predict discharge outcome and tested performance using 5-fold cross validation. 

113 patients met study criteria, and 91 (80.53%) had poor GOS at discharge. Our best model, a random forest with 60 trees, included global and cumulative ADR, total power, delta power, alpha power, percent alpha variability, and ED burden. The model predicted discharge outcome with area under the receiver operating characteristic curve (AUC)=0.707-0.769 2-10 days post-SAH. The model performed the best 4.5 days post-SAH (AUC=0.769; 95% Confidence Interval=[0.720, 0.812]). The three features with the highest predictor importance estimates were cumulative ED burden, PAV, and total power. We compared the results of our algorithm with a logistic regression of Hunt-Hess at admission as a predictor (AUC=0.686, 95% CI=[0.571-0.800]).

Automated calculations of qEEG features can be used in a random forest model to predict SAH outcome.

Authors/Disclosures
Hsin Yi Chen
PRESENTER
Miss Chen has nothing to disclose.
Wei-Long Zheng (MGH) No disclosure on file
Sahar Zafar, MD Dr. Zafar has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer. Dr. Zafar has received research support from NIH. Dr. Zafar has received personal compensation in the range of $5,000-$9,999 for serving as a Speaker for a lecture with Marinus.
Jonathan Elmer No disclosure on file
No disclosure on file
No disclosure on file
Aman Patel Aman Patel has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Microvention. Aman Patel has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Stryker. Aman Patel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic. Aman Patel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Penumbra.
Eric Rosenthal, MD (Massachusetts General Hospital) Dr. Rosenthal has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Pharma, Inc. . Dr. Rosenthal has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ceribell, Inc. . The institution of Dr. Rosenthal has received research support from Sage Therapeutics. Dr. Rosenthal has received intellectual property interests from a discovery or technology relating to health care.
Emily J. Gilmore, MD (Yale University School of Medicine) Dr. Gilmore has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for carpl.ai. Dr. Gilmore has received personal compensation in the range of $0-$499 for serving as a Consultant for AAN. Dr. Gilmore has received research support from NIH.
M. B. Westover, MD, PhD (MGH) Dr. Westover has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Beacon Biosignals. Dr. Westover has stock in Beacon Biosignals. The institution of Dr. Westover has received research support from NIH. Dr. Westover has received publishing royalties from a publication relating to health care. Dr. Westover has a non-compensated relationship as a cofounder with Beacon Biosignals that is relevant to AAN interests or activities.
Jennifer A. Kim, MD (Yale University School of Medicine) Dr. Kim has nothing to disclose.